PTC Therapeutics (PTCT) shares were down over 7% in recent Monday trading after RBC downgraded the stock to sector perform from outperform.
Trading volume was more than 1.9 million shares, compared with a daily average of about 1.5 million.
Price: 79.70, Change: -6.30, Percent Change: -7.32